Feature Channels:

Neuro

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

zika virus, Protease, NS3, NS2B, Inhibitors

New Zika Virus Inhibitor Identified

140794_web.jpg

Compound could serve as basis for drugs to prevent neurological complications of Zika

Medicine

Channels:

Stem Cells, Diseases, Pharmaceuticals, Brain, Neurological Deficits, Thyroid Hormone

Patient’s cells used to replicate dire developmental condition

A team of scientists from the University of Wisconsin-Madison and Cedars-Sinai in Los Angeles have used the cells of AHDS patients to recreate not only the disease, but a mimic of the patient’s blood-brain barrier in the laboratory dish using induced pluripotent stem cell technology.

Medicine

Channels:

Multiple Sclerosis (MS), Neurology, smartphone app, Research Trial, 23andMe, MRI, Tech, app development, Pilot Study, USC, University Of Southern California, Keck Medicine of USC, Keck School Of Medicine, Genetics, Health Care Technology, Technology, MS, Daniel Pelletier

Unlocking the Mystery of Multiple Sclerosis with Tech

myMShomescreen.jpg

Recruitment begins for a Keck School of Medicine of USC study of the first smartphone app to combine clinical data, MRI imaging and genetic data for people with multiple sclerosis

Medicine

Science

Channels:

Moral Behavior, Moral Enhancement, Technology, Pharmaceticals, Surgery, Neurotechnology, Oxytocin, Amphetamine, SSRI, Beta Blockers, Transcranial Magnetic Stimulation, transcranial direct current stimulation, Deep Brain Stimulation, Research

Study: ‘Moral Enhancement’ Technologies Are Neither Feasible Nor Wise

A recent study finds that “moral enhancement technologies” – which are discussed as ways of improving human behavior – are neither feasible nor wise, based on an assessment of existing research into these technologies.

Medicine

Channels:

Ritalin, Attention Deficit Hyperactivity Disorder, ADHD, study enhancer, stimulant drugs, Methylphenidate, brain growth, Brain Development

Nonprescription Use of Ritalin Linked to Adverse Side Effects, UB Study Finds

New research from the University at Buffalo Research Institute on Addictions that explored the potential side effects of the stimulant drug Ritalin on those without ADHD showed changes in brain chemistry associated with risk-taking behavior, sleep disruption and other undesirable effects.

Medicine

Channels:

Multiple Sclerosis (MS), MS, Rehabiliation, Telemedicine, Telerehabilitation, lakeshore foundation, UAB, University of Alabama at Birmingham

UAB / Lakeshore Research Collaborative Awarded $5.8M for MS Research

RS16919_telehealth_graphic-scr.jpg

The grant will help fund a study to determine whether people with multiple sclerosis get as much benefit from an exercise-based rehabilitation program delivered via internet and telephone as they do when the therapy is provided in a clinic.

Medicine

Channels:

Dementia, Lewy Body Dementia, Parkinson's Disease, REP, Parkinsonism, Rochester Epidemiology Project

Study Offers Answers on Life Expectancy for People with Parkinson’s Disease, Lewy Body Dementia

Faced with a serious disease, patients want to know the answer to a difficult question: “How long will I live?”

Medicine

Channels:

Stem Cell Trial for Stroke Patients Suffering Chronic Motor Deficits Begins at UTHealth

2012Savitzheadshot.jpg

A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Medicine

Channels:

Spinal Muscular Atrophy: New Clues to Cause and Treatment

forPRESSRELEASE11.jpg

Spinal muscular atrophy is partly due to defects in the sensory neuron synapses that activate motor neurons. Symptoms may be reduced by improving synapse function.

Medicine

Channels:

ALS, Gene, Lou Gehrig disease, Developmental Biology

New Gene Identified in Lou Gehrig’s Disease

Yong-ChaoMa.jpg

For the first time, a variant in UBQLN4 gene has been associated with Lou Gehrig’s disease or amyotrophic lateral sclerosis (ALS) – a progressive disease resulting in the loss of nerve cells that control muscle movement, which eventually leads to paralysis and death. The study published in the journal eLife also describes how this gene variant disrupts a cellular process that drives motor neuron development. This new insight opens the door to potential treatment targets for ALS.







Chat now!